Fortress Biotech, Inc. (FBIO)
3.36
-0.12
(-3.45%)
USD |
NASDAQ |
Feb 20, 16:00
3.37
+0.01
(+0.30%)
After-Hours: 20:00
Fortress Biotech Profit Margin (Quarterly) : 50.07% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 36.91% |
| Oramed Pharmaceuticals, Inc. | -- |
| Lyell Immunopharma, Inc. | -259.0K% |
| Climb Bio, Inc. | -- |
| Moderna, Inc. | -121.8% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -223.1% |
| Return on Assets | -34.04% |
| Return on Invested Capital | -56.09% |
| Gross Profit Margin (Quarterly) | 60.80% |
| Operating Margin (Quarterly) | -38.63% |
| Return on Net Operating Assets | -75.46% |